Detalhe da pesquisa
1.
Office measurement vs. ambulatory blood pressure monitoring: associations with mortality in patients with or without diabetes.
Eur Heart J
; 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38847237
2.
Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients.
Lancet
; 401(10393): 2041-2050, 2023 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156250
3.
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
N Engl J Med
; 385(24): 2252-2263, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34449181
4.
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
Diabetes Obes Metab
; 26(1): 191-200, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37814928
5.
Targeting the TWEAK-Fn14 pathway prevents dysfunction in cardiac calcium handling after acute kidney injury.
J Pathol
; 261(4): 427-441, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776271
6.
Physical activity, chronic kidney disease, and cardiovascular risk: A study in half a million adults.
Scand J Med Sci Sports
; 34(1): e14557, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268077
7.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Ann Intern Med
; 176(12): 1606-1616, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048573
8.
Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation.
Eur Heart J
; 44(21): 1874-1889, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005351
9.
Prevention of cardiorenal damage: importance of albuminuria.
Eur Heart J
; 44(13): 1112-1123, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477861
10.
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.
Circulation
; 145(6): 437-447, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775784
11.
A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes.
Kidney Int
; 103(1): 196-206, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36367466
12.
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
N Engl J Med
; 383(23): 2219-2229, 2020 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33264825
13.
Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis.
Am J Nephrol
; 54(9-10): 370-378, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708857
14.
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study.
Nephrol Dial Transplant
; 38(2): 372-383, 2023 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35451488
15.
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.
Nephrol Dial Transplant
; 38(1): 10-25, 2023 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33944938
16.
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use.
Diabetes Obes Metab
; 25(2): 407-416, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36193847
17.
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.
Diabetes Obes Metab
; 25(10): 2989-2998, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402696
18.
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.
Diabetes Obes Metab
; 25(6): 1512-1522, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722675
19.
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial.
J Am Soc Nephrol
; 33(1): 225-237, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34732509
20.
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.
Eur Heart J
; 43(6): 474-484, 2022 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35023547